[1] SANCHEZ-LOPEZ E, CORAS R, TORRES A, et al. Guma M. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022;18(5):258-275.
[2] MARTEL-PELLETIER J, BARR AJ, CICUTTINI FM, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072.
[3] MOBASHERI A, BAY-JENSEN AC, VAN SPIL WE, et al. Levesque MC. Osteoarthritis Year in Review 2016: biomarkers (biochemical markers). Osteoarthritis Cartilage. 2017;25(2):199-208.
[4] ALI SA, PEFFERS MJ, ORMSETH MJ, et al. The non-coding RNA interactome in joint health and disease. Nat Rev Rheumatol. 2021;17(11):692-705.
[5] GHOURI A, QUICKE JG, CONAGHAN PG. New developments in osteoarthritis pharmacological therapies. Rheumatology (Oxford). 2021;60(Suppl 6):vi1-vi11.
[6] BRUMAT P, KUNŠIČ O, NOVAK S, et al. The Surgical Treatment of Osteoarthritis. Life (Basel). 2022;12(7):982.
[7] ZHOU J, XIONG W, GOU P, et al. Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study. J Orthop Surg Res. 2020;15(1):230.
[8] LIU D, LIANG YH, YANG YT, et al. Circular RNA in osteoarthritis: an updated insight into the pathophysiology and therapeutics. Am J Transl Res. 2021;13(1):11-23.
[9] BOER CG, HATZIKOTOULAS K, SOUTHAM L, et al. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations. Cell. 2021;184(18):4784-4818.e17.
[10] HUNTER DJ, BIERMA-ZEINSTRA S. Osteoarthritis. Lancet. 2019;393 (10182): 1745-1759.
[11] LIU HY, CHANG CF, LU CC, et al. The Role of Mitochondrial Metabolism, AMPK-SIRT Mediated Pathway, LncRNA and MicroRNA in Osteoarthritis. Biomedicines. 2022;10(7):1477.
[12] MAO X, CAO Y, GUO Z, et al. Biological roles and therapeutic potential of circular RNAs in osteoarthritis. Mol Ther Nucleic Acids. 2021;24:856-867.
[13] YAN H, BU P. Non-coding RNA in cancer. Essays Biochem. 2021;65(4):625-639.
[14] SALMENA L, POLISENO L, TAY Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353-358.
[15] NIE D, FU J, CHEN H, et al. Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential. Int J Mol Sci. 2019;20(4):861.
[16] IZAURRALDE E. A role for eIF4AII in microRNA-mediated mRNA silencing. Nat Struct Mol Biol. 2013;20(5):543-545.
[17] YAO RW, WANG Y, CHEN LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542-551.
[18] RUAN X, LI P, CHEN Y, et al. In vivo functional analysis of non-conserved human lncRNAs associated with cardiometabolic traits. Nat Commun. 2020;11(1):45.
[19] BRIDGES MC, DAULAGALA AC, KOURTIDIS A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2):e202009045.
[20] LI J, YANG T, TANG H, et al. Inhibition of lncRNA MAAT Controls Multiple Types of Muscle Atrophy by cis- and trans-Regulatory Actions. Mol Ther. 2021;29(3):1102-1119.
[21] NAPOLI M, LI X, ACKERMAN HD, et al. Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation. Nat Commun. 2020;11(1):5156.
[22] SHIGEYASU K, TODEN S, OZAWA T, et al. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer. Mol Cancer. 2020;19(1):155.
[23] KONG H, SUN ML, ZHANG XA, et al. Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis. Front Cell Dev Biol. 2021;9:774370.
[24] GRAMMATIKAKIS I, LAL A. Significance of lncRNA abundance to function. Mamm Genome. 2022;33(2):271-280.
[25] NÚÑEZ-MARTÍNEZ HN, RECILLAS-TARGA F. Emerging Functions of lncRNA Loci beyond the Transcript Itself. Int J Mol Sci. 2022;23(11):6258.
[26] ZHANG X, HONG R, CHEN W, et al. The role of long noncoding RNA in major human disease. Bioorg Chem. 2019;92:103214.
[27] WU W, CAO L, JIA Y, et al. Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma. Cells. 2022;11(18):2920.
[28] QIU Y, XU M, HUANG S. Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis. Blood. 2021;138(23):2327-2336.
[29] HARTFORD CCR, LAL A. When Long Noncoding Becomes Protein Coding. Mol Cell Biol. 2020;40(6):e00528-e00519.
[30] CHARLES RICHARD JL, EICHHORN PJA. Platforms for Investigating LncRNA Functions. SLAS Technol. 2018;23(6):493-506.
[31] ROBINSON EK, COVARRUBIAS S, CARPENTER S. The how and why of lncRNA function: An innate immune perspective. Biochim Biophys Acta Gene Regul Mech. 2020;1863(4):194419.
[32] REN S, LIN P, WANG J, et al. Circular RNAs: Promising Molecular Biomarkers of Human Aging-Related Diseases via Functioning as an miRNA Sponge. Mol Ther Methods Clin Dev. 2020;18:215-229.
[33] CHEN I, CHEN CY, CHUANG TJ. Biogenesis, identification, and function of exonic circular RNAs. Wiley Interdiscip Rev RNA. 2015;6(5):563-579.
[34] SHANG Q, YANG Z, JIA R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6.
[35] MENG S, ZHOU H, FENG Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94.
[36] MAO X, CAO Y, GUO Z, et al. Biological roles and therapeutic potential of circular RNAs in osteoarthritis. Mol Ther Nucleic Acids. 2021;24:856-867.
[37] LI B, LI Y, HU L, et al. Role of Circular RNAs in the Pathogenesis of Cardiovascular Disease. J Cardiovasc Transl Res. 2020;13(4):572-583.
[38] HOLDT LM, KOHLMAIER A, TEUPSER D. Molecular roles and function of circular RNAs in eukaryotic cells. Cell Mol Life Sci. 2018;75(6):1071-1098.
[39] TANG CM, ZHANG M, HUANG L, et al. CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts. Sci Rep. 2017;7:40342.
[40] HAN B, CHAO J, YAO H. Circular RNA and its mechanisms in disease: From the bench to the clinic. Pharmacol Ther. 2018;187:31-44.
[41] GUO L, JIA L, LUO L, et al. Critical Roles of Circular RNA in Tumor Metastasis via Acting as a Sponge of miRNA/isomiR. Int J Mol Sci. 2022; 23(13):7024.
[42] AKHBARI MH, ZAFARI Z, SHEYKHHASAN M. Competing Endogenous RNAs (ceRNAs) in Colorectal Cancer: A Review. Expert Rev Mol Med. 2022;24:e27.
[43] CAO M, ZHANG L, WANG JH, et al. Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice. Int J Med Sci. 2019;16(10):1356-1365.
[44] LIU D, LIANG YH, YANG YT, et al. Circular RNA in osteoarthritis: an updated insight into the pathophysiology and therapeutics. Am J Transl Res. 2021;13(1):11-23.
[45] ZANG J, LU D, XU A. The interaction of circRNAs and RNA binding proteins: An important part of circRNA maintenance and function. J Neurosci Res. 2020;98(1): 87-97.
[46] KHAN FA, NSENGIMANA B, KHAN NH, et al. Chimeric Peptides/Proteins Encoded by circRNA: An Update on Mechanisms and Functions in Human Cancers. Front Oncol. 2022;12:781270.
[47] STASIAK M, KOLENDA T, KOZŁOWSKA-MASŁOŃ J, et al. The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules? Life (Basel). 2021;11(12):1354.
[48] JACQ C, MILLER JR, BROWNLEE GG. A pseudogene structure in 5S DNA of Xenopus laevis. Cell. 1977;12(1):109-120.
[49] QI Y, WANG X, LI W, et al. Pseudogenes in Cardiovascular Disease. Front Mol Biosci. 2021;7:622540.
[50] LIU WH, TSAI ZT, TSAI HK. Comparative genomic analyses highlight the contribution of pseudogenized protein-coding genes to human lincRNAs. BMC Genomics. 2017;18(1):786.
[51] HEZRONI H, BEN-TOV PERRY R, MEIR Z, et al. A subset of conserved mammalian long non-coding RNAs are fossils of ancestral protein-coding genes. Genome Biol. 2017;18(1):162.
[52] MA Y, CHEN Z, YU J. Pseudogenes and their potential functions in hematopoiesis. Exp Hematol. 2021;103:24-29.
[53] ABRAMOFF B, CALDERA FE. Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Med Clin North Am. 2020;104(2):293-311.
[54] MAO L, WU W, WANG M, et al. Targeted treatment for osteoarthritis: drugs and delivery system. Drug Deliv. 2021;28(1):1861-1876.
[55] ZHANG W, QI L, CHEN R, et al Circular RNAs in osteoarthritis: indispensable regulators and novel strategies in clinical implications. Arthritis Res Ther. 2021; 23(1):23.
[56] Tu J, Huang W, Zhang W, et al. The emerging role of lncRNAs in chondrocytes from osteoarthritis patients. Biomed Pharmacother. 2020;131:110642.
[57] OKUYAN HM, BEGEN MA. LncRNAs in Osteoarthritis. Clin Chim Acta. 2022;532: 145-163.
[58] XING D, LIANG JQ, LI Y, et al. Identification of long noncoding RNA associated with osteoarthritis in humans. Orthop Surg. 2014;6(4):288-293.
[59] LU X, YU Y, YIN F, et al. Knockdown of PVT1 inhibits IL-1β-induced injury in chondrocytes by regulating miR-27b-3p/TRAF3 axis. Int Immunopharmacol. 2020;79:106052.
[60] MAO G, KANG Y, LIN R, et al. Long Non-coding RNA HOTTIP Promotes CCL3 Expression and Induces Cartilage Degradation by Sponging miR-455-3p. Front Cell Dev Biol. 2019;7:161.
[61] HU J, WANG Z, SHAN Y, et al. Long non-coding RNA HOTAIR promotes osteoarthritis progression via miR-17-5p/FUT2/β-catenin axis. Cell Death Dis. 2018;9(7):711.
[62] ZHANG G, ZHANG Q, ZHU J, et al. LncRNA ARFRP1 knockdown inhibits LPS-induced the injury of chondrocytes by regulation of NF-κB pathway through modulating miR-15a-5p/TLR4 axis. Life Sci. 2020;261:118429.
[63] CHEN K, FANG H, XU N. LncRNA LOXL1-AS1 is transcriptionally activated by JUND and contributes to osteoarthritis progression via targeting the miR-423-5p/KDM5C axis. Life Sci. 2020;258:118095.
[64] LIU Y, LIU K, TANG C, et al. Long non-coding RNA XIST contributes to osteoarthritis progression via miR-149-5p/DNMT3A axis. Biomed Pharmacother. 2020;128: 110349.
[65] CHEN C, YIN P, HU S, et al. Circular RNA-9119 protects IL-1β-treated chondrocytes from apoptosis in an osteoarthritis cell model by intercepting the microRNA-26a/PTEN axis. Life Sci. 2020;256:117924.
[66] LI BF, ZHANG Y, XIAO J, et al. Hsa_circ_0045714 regulates chondrocyte proliferation, apoptosis and extracellular matrix synthesis by promoting the expression of miR-193b target gene IGF1R. Hum Cell. 2017;30(4):311-318.
[67] CHEN G, LIU T, YU B, et al. CircRNA-UBE2G1 regulates LPS-induced osteoarthritis through miR-373/HIF-1a axis. Cell Cycle. 2020;19(13):1696-1705.
[68] ZHANG J, CHENG F, RONG G, et al. Hsa_circ_0005567 Activates Autophagy and Suppresses IL-1β-Induced Chondrocyte Apoptosis by Regulating miR-495. Front Mol Biosci. 2020;7:216.
[69] WANG T, HAO Z, LIU C, et al. LEF1 mediates osteoarthritis progression through circRNF121/miR-665/MYD88 axis via NF-кB signaling pathway. Cell Death Dis. 2020;11(7):598.
[70] SHEN P, YANG Y, LIU G, et al. CircCDK14 protects against Osteoarthritis by sponging miR-125a-5p and promoting the expression of Smad2. Theranostics. 2020;10(20):9113-9131.
[71] CHEN X, WAN L, WANG W, et al. Re-recognition of pseudogenes: From molecular to clinical applications. Theranostics. 2020;10(4):1479-1499.
[72] LIU Q, HU X, ZHANG X, et al. The TMSB4 Pseudogene LncRNA Functions as a Competing Endogenous RNA to Promote Cartilage Degradation in Human Osteoarthritis. Mol Ther. 2016;24(10):1726-1733.
[73] YU H, HUANG T, LU WW, et al. Osteoarthritis Pain. Int J Mol Sci. 2022; 23(9):4642.
[74] KONG H, SUN ML, ZHANG XA, et al. Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis. Front Cell Dev Biol. 2021;9:774370.
[75] WANG C, LI N, LIU Q, et al. The role of circRNA derived from RUNX2 in the serum of osteoarthritis and its clinical value. J Clin Lab Anal. 2021;35(7):e23858.
[76] YANG Z, TANG Y, LU H, et al. Long non-coding RNA reprogramming (lncRNA-ROR) regulates cell apoptosis and autophagy in chondrocytes. J Cell Biochem. 2018;119(10):8432-8440. |